This is archived web content selected for preservation by The National Archives. This snapshot was taken on 05/03/2007. See all dates available for this archived website. External links, forms and search boxes may not function within these archived websites.
Find more about web archiving at The National Archives.

Primary Navigation - link to other main sections from here

Skip Navigation

Blood

Policy and guidance about blood pressure, deep vein thrombosis (DVT), the use of blood and blood products in the NHS, and bloodborne viruses including hepatitis B, hepatitis C and HIV.

Red cell contingency

Published:
18 September 2006

The CMO’s National Blood Transfusion Committee sub group on contingency planning prepared an integrated plan to address red cell shortages. The sub group has now developed an extension to the red cell plan that lists actions to be taken by both the National Blood Service (NBS) and hospitals in the event of a platelet shortage.



NHS Blood and Transplant

As part of the Arm’s Length Bodies review the National Blood Authority (NBA), which manages the National Blood Service, Bio Products Laboratory and the International Blood Group Reference Laboratory, and UK Transplant (UKT) merged on 1 October 2005 to form a new organisation, NHS Blood and Transplant (NHSBT).



Blood safety general information

About the donation and use of blood and blood products in the NHS.



Bloodborne viruses

The most common serious viruses carried in people’s bloodstreams are hepatitis B, hepatitis C and HIV.



Blood pressure

High blood pressure, known as hypertension, is a major cause of strokes, coronary heart disease and other illnesses including kidney disease and aortic aneurysm.



Venous Thromboembolism (VTE)

Venous thrombosis is a condition in which a blood clot (thrombus) forms in a vein.Blood flow through the affected vein can be limited by the clot, causing swelling and pain. Deep vein thrombosis (DVT) and pulmonary embolism are the most common manifestations of venous thrombosis.



Self-sufficiency in blood products in England and Wales: A chronology from 1973 to 1991

Published:
27 February 2006

About 3000 haemophilia patients treated with blood products in the 1970s and early 1980s were infected with hepatitis C (HCV), and many with HIV. A number of MPs suggested that this might have been avoided had the UK achieved self-sufficiency in blood products, a policy the Government initiated in 1975. This report is the result of a review of surviving documents from 1973 (when a decision was made to pursue self-sufficiency for England and Wales) to 1991 (when a validated screening test for HCV was introduced in the UK).



Committees

Roll-out of recombinant clotting factors for all adult haemophilia patients in England

The Recombinant Clotting Factors Working Group advises the Department of Health on a strategy for the phased introduction of recombinant clotting factors for the treatment of adult haemophilia in England.

The National Blood Transfusion Committee

The overall objective of the National Blood Transfusion Committee and the Regional Transfusion Committees is to promote safe and effective good transfusion practice in hospitals in accordance with the Better Blood Transfusion initiative and the Health Service Circular.

Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation

Papers from Committee Meetings, Public Summaries, Minutes



National Blood Service

National Blood Service logo

Part of the NHS which delivers blood, blood components, blood products and tissues from 15 national blood centres. It also carries out research into improving the safety of blood. National Blood Service is part of NHS Blood and Transplant

Roll-out of recombinant clotting factors for all adult haemophilia patients in England

The Recombinant Clotting Factors Working Group advises the Department of Health on a strategy for the phased introduction of recombinant clotting factors for the treatment of adult haemophilia in England.


Global Tools - quick links to useful sections